Controlling Residual Host Cell Proteins (HCP) Impurities in Biopharmaceuticals Biotherapeutics must be free of Bioprocess-related impurities, including protein contaminants derived from the Host Cell used as the expression system (bacterium, yeast, mammalian, insect or plant cells). HCP fit the definition of the Critical Quality Attribute (CQA) due to their potential … Continue reading →